Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.63 |
| ▸ | NPC1 | O15118 | 6/20 | 0.63 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.55 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CTSD | P07339 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | STAT3 | P40763 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9915082 | 0.85 | NPC1 (0.52) | RAB9ANPC1LMNAKMT2AALDH1A1 | |
| SCHEMBL27766568 | 0.83 | CTSD (0.56) | RAB9ANPC1KCNK3KCNK9KMT2A | |
| SCHEMBL9915151 | 0.80 | ALDH1A1 (0.54) | RAB9ANPC1KCNK3KCNK9KMT2A | |
| SCHEMBL9915153 | 0.77 | NPC1 (0.58) | RAB9ANPC1KCNK9KMT2AKDM4E | |
| SCHEMBL9274738 | 0.76 | ALOX15 (0.52) | RAB9ANPC1KCNK3KCNK9KMT2A | |
| SCHEMBL9915152 | 0.75 | RAB9A (0.66) | RAB9ANPC1KCNK3KCNK9KMT2A | |
| SCHEMBL11570198 | 0.75 | HDAC3 (0.50) | RAB9ANPC1KCNK3KCNK9LMNA | |
| SCHEMBL9915156 | 0.74 | POLB (0.57) | RAB9ANPC1LMNAKMT2AALDH1A1 | |
| SCHEMBL10417548 | 0.73 | CTSD (0.55) | RAB9ANPC1KCNK3KCNK9KMT2A | |
| SCHEMBL29573531 | 0.73 | MAPT (0.64) | RAB9ANPC1KCNK3KCNK9LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096504-B2 | Controlled chemical release of hydrogen sulfide | WASHINGTON STATE UNIVERSITY (US) | 2015-08-04 | — | — | US | disclosed |
| US-20130253051-A1 | CONTROLLED CHEMICAL RELEASE OF HYDROGEN SULFIDE | WASHINGTON STATE UNIVERSITY (US) | 2013-09-26 | — | — | US | disclosed |
| WO-2012075242-A2 | CONTROLLED CHEMICAL RELEASE OF HYDROGEN SULFIDE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2012-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130253051-A1 | CONTROLLED CHEMICAL RELEASE OF HYDROGEN SULFIDE | GSR, AR, GRHPR | RAB9A 3033/4885NPC1 2731/4885KCNK3 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.